KDM5 inhibition is a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas [2]
Ontology highlight
ABSTRACT: KDM5 inhibition is a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas [2]
PROVIDER: PRJNA639892 | ENA |
REPOSITORIES: ENA
ACCESS DATA